Three people who have attended a Biogen management meeting in Boston have tested positive for COVID-19 coronavirus. The meeting hosted around 175 co-workers over two days in a Boston hotel. Before Biogen disclosed these infections, there were only three cases of Coronavirus in Massachusetts. Several other attendees from the meeting reported having flu-like symptoms afterward […]
Cancer Research UK (CRUK) has funded a project run by a team of researchers at the University of Bristol to develop a new blood-based test for early diagnosis of brain cancer. The researchers are planning to deploy the point-of-care (POC) assay based on a fluorescent nanophotonics platform, which is a platform that studies the behaviour […]
Singapore’s Health Sciences Authority has authorised clinical use of a new test for SARS-CoV-2 according to the Agency for Science, Technology, and Research (A*STAR).
Thermo Fisher has agreed to buy Qiagen in an $11.5bn deal.
Recent analysis of the genetic sequence of the coronavirus has indicated that the infection may have spread further than we realised.
Researchers hope that the effort will be able to validate liquid biopsy (LB) diagnostic methods for childhood lymphomas that are endemic in the region
The catalogue, Human Vaginal Non-Redundant gene catalogue (VIRGO), has been released publicly and can be used to facilitate an in-depth understanding of how the vaginal micro-organisms affect women’s health
MedImpact is the first pharmacy benefit manager (PBM) in the US to alert prescribers based on their genetic profile.
John Hopkins University has announced a partnership with Cambridge-based start-up, Capsulomics, to study the detection of oesophageal cancer and Barrett’s oesophagus.
Yesterday, a test developed by Co-diagnostics for the detection of SARS-CoV-2, received CE marking as the virus nears “pandemic” status. CE-IVD marking indicates that the IVD conforms with relevant EU directives regarding the health and safety of the product.
Aging affects everyone, right down to our genetic core, but there’s plenty of evidence showing that each individual experiences the effects of age differently. As it turns out, some people are predisposed to a less disruptive (a kinder, gentler) aging process. New research hopes to uncover why that is.
Late on Friday, the FDA authorised the marketing of the first genetic test for Fragile X syndrome (FXS): AmplideX, a Fragile X diagnostic and carrier screen kit from Asuragen. The press release can be found here.
York Governor, Andrew Cuomo, announced legislation to launch a consortium of public and private research groups to investigate the genetics of Alzheimer’s disease. The five-year initiative, called the SUNY Curing Alzheimer’s Health Consortium, will analyse the genetics of 1 million people who suffer from or are at risk of developing Alzheimer’s disease over 5 years.
Researchers from the Wellcome Sanger Institute have just released the first high-quality Eurasian Otter (Lutra lutra) genome in partnership with the Cardiff University Otter project, aiming to support the study of their biology and support conservation efforts.
Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects their drug response and metabolism. An understanding of PGx could help clinicians make prescribing decisions and has the potential to be implemented in routine care worldwide. PGx has understandably been gaining traction and support, with pharmacogenomic elements being implemented into many international Genomic studies.